Chase C. Leavitt, General Counsel/Secretary at Oncternal Therapeutics, Inc. (ONCT), bought 1,500 shares at $5.45 ($8K) on 2021-06-11, disclosed to the SEC on 2021-06-15.
Open-market purchase of $8k ONCT by General Counsel/Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ONCT | BUY | 2023-04-14 | $7K | — | Filing → |
| ONCT | BUY | 2022-01-31 | $23K | — | Filing → |
| LCTX | BUY | 2019-08-15 | $5K | — | Filing → |